---
title: Clarenta vs Quanticate
slug_a: comac-medical
slug_b: quanticate
site: cro
review_signal_gate: closed
canonical_path: /compare/comac-medical/quanticate
generated_by: BioBM Editorial AI
---

# Clarenta vs Quanticate

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Clarenta (comac-medical) is listed for cro. Clarenta (formerly Comac Medical Group) is a pan-European CRO offering full-service trial delivery and early-phase studies, including first-in-human and PK work. It runs a Phase I unit in Sofia and has depth in oncology and rare diseases.

Services: 8. Modalities: 0. Indications: 7. Locations: 10. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (10).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Quanticate (quanticate) is listed for cro. Quanticate is a biometrics CRO with 30 years of expertise in biostatistics, clinical data management, and pharmacovigilance across all clinical trial phases. The company specializes in statistical protocol design, CDISC standards compliance, and real-world data analysis to support regulatory submissions.

Services: 6. Modalities: 0. Indications: 0. Locations: 8. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (8).

Review summary: Review summary withheld until site-level review gate opens.